ArticleFrontiers in medicine2026
Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study.
Li Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.